HomeOCX • NASDAQ
add
OncoCyte Corp
Previous close
$3.00
Day range
$2.91 - $3.05
Year range
$2.08 - $4.86
Market cap
39.96M USD
Avg Volume
42.39K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 176.00K | -40.74% |
Operating expense | 5.71M | -8.73% |
Net income | -9.13M | -400.99% |
Net profit margin | -5.19K | -607.92% |
Earnings per share | -0.68 | 54.62% |
EBITDA | -5.45M | 5.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 5.58M | -54.86% |
Total assets | 70.97M | -14.28% |
Total liabilities | 54.05M | 37.42% |
Total equity | 16.92M | — |
Shares outstanding | 13.36M | — |
Price to book | 2.14 | — |
Return on assets | -19.83% | — |
Return on capital | -59.38% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -9.13M | -400.99% |
Cash from operations | -3.83M | 53.86% |
Cash from investing | -24.00K | 98.25% |
Cash from financing | — | — |
Net change in cash | -3.85M | 60.27% |
Free cash flow | -1.56M | 54.10% |
About
Founded
2009
Headquarters
Website
Employees
45